These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 10950755

  • 1. Cytomegalovirus infection decreases expression of thrombospondin-1 and -2 in cultured human retinal glial cells: effects of antiviral agents.
    Cinatl J, Bittoova M, Margraf S, Vogel JU, Cinatl J, Preiser W, Doerr HW.
    J Infect Dis; 2000 Sep; 182(3):643-51. PubMed ID: 10950755
    [Abstract] [Full Text] [Related]

  • 2. Antisense oligonucleotide ISIS 2922 targets IE-expression and prevents HCMV-IE-induced suppression of TSP-1 and TSP-2 expression.
    Margraf S, Bittoova M, Vogel JU, Kotchekov R, Doerr HW, Cinatl J.
    Nucleosides Nucleotides Nucleic Acids; 2001 Sep; 20(4-7):1425-8. PubMed ID: 11563036
    [Abstract] [Full Text] [Related]

  • 3. Human cytomegalovirus infection decreases expression of thrombospondin-1 independent of the tumor suppressor protein p53.
    Cinatl J, Kotchetkov R, Scholz M, Cinatl J, Vogel JU, Driever PH, Doerr HW.
    Am J Pathol; 1999 Jul; 155(1):285-92. PubMed ID: 10393860
    [Abstract] [Full Text] [Related]

  • 4. Targeting the NF-kappaB pathway through pharmacological inhibition of IKK2 prevents human cytomegalovirus replication and virus-induced inflammatory response in infected endothelial cells.
    Caposio P, Musso T, Luganini A, Inoue H, Gariglio M, Landolfo S, Gribaudo G.
    Antiviral Res; 2007 Mar; 73(3):175-84. PubMed ID: 17070604
    [Abstract] [Full Text] [Related]

  • 5. Replication of human cytomegalovirus in human retinal glial cells.
    Burd EM, Pulido JS, Puro DG, O'Brien WJ.
    Invest Ophthalmol Vis Sci; 1996 Sep; 37(10):1957-66. PubMed ID: 8814135
    [Abstract] [Full Text] [Related]

  • 6. Valproic acid interferes with antiviral treatment in human cytomegalovirus-infected endothelial cells.
    Michaelis M, Ha TA, Doerr HW, Cinatl J.
    Cardiovasc Res; 2008 Feb 01; 77(3):544-50. PubMed ID: 18006438
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Activation of the virus-induced IKK/NF-kappaB signalling axis is critical for the replication of human cytomegalovirus in quiescent cells.
    Caposio P, Luganini A, Hahn G, Landolfo S, Gribaudo G.
    Cell Microbiol; 2007 Aug 01; 9(8):2040-54. PubMed ID: 17419715
    [Abstract] [Full Text] [Related]

  • 9. Human cytomegalovirus infection modulates thrombospondins 1 and 2 in primary fetal astrocytes.
    Zhang L, Li L, Wang B, Qian DM, Song XM, Hu M.
    Neuroreport; 2013 Jul 10; 24(10):526-35. PubMed ID: 23660684
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of human cytomegalovirus replication in a human retinal epithelial cell model by antisense oligonucleotides.
    Detrick B, Nagineni CN, Grillone LR, Anderson KP, Henry SP, Hooks JJ.
    Invest Ophthalmol Vis Sci; 2001 Jan 10; 42(1):163-9. PubMed ID: 11133862
    [Abstract] [Full Text] [Related]

  • 11. Inhibitory effect of hexamethylene bisacetamide on replication of human cytomegalovirus.
    Kitagawa R, Hagihara K, Uhara M, Matsutani K, Kirita A, Tanaka J.
    Arch Virol; 2005 Oct 10; 150(10):1977-91. PubMed ID: 15959837
    [Abstract] [Full Text] [Related]

  • 12. Hexamethylene bisacetamide can convert nonpermissive human cells to a permissive state for expressing the major immediate-early genes of human cytomegalovirus by up-regulating NF-kappaB activity.
    Kitagawa R, Takahashi Y, Takahashi M, Imazu H, Yasuda M, Sadanari H, Tanaka J.
    Virology; 2009 Jan 20; 383(2):195-206. PubMed ID: 19027925
    [Abstract] [Full Text] [Related]

  • 13. Bcl-3-regulated transcription from major immediate-early promoter of human cytomegalovirus in monocyte-derived macrophages.
    Khan KA, Coaquette A, Davrinche C, Herbein G.
    J Immunol; 2009 Jun 15; 182(12):7784-94. PubMed ID: 19494302
    [Abstract] [Full Text] [Related]

  • 14. Differential patterns of human cytomegalovirus gene expression in various T-cell lines carrying human T-cell leukemia-lymphoma virus type I: role of Tax-activated cellular transcription factors.
    Beck Z, Bácsi A, Liu X, Ebbesen P, Andirkó I, Csoma E, Kónya J, Nagy E, Tóth FD.
    J Med Virol; 2003 Sep 15; 71(1):94-104. PubMed ID: 12858414
    [Abstract] [Full Text] [Related]

  • 15. [In vitro infection of human megakaryocyte precursors by human cytomegalovirus (HCMV) and the antiviral effect of HCMV antisense oligonucleotides].
    Yao JX, Cui GH, Xia LH, Song SJ.
    Zhonghua Xue Ye Xue Za Zhi; 2004 Dec 15; 25(12):720-3. PubMed ID: 15730713
    [Abstract] [Full Text] [Related]

  • 16. Experimental study on the action of allitridin against human cytomegalovirus in vitro: Inhibitory effects on immediate-early genes.
    Zhen H, Fang F, Ye DY, Shu SN, Zhou YF, Dong YS, Nie XC, Li G.
    Antiviral Res; 2006 Oct 15; 72(1):68-74. PubMed ID: 16844239
    [Abstract] [Full Text] [Related]

  • 17. Human cytomegalovirus productively infects adrenocortical cells and induces an early cortisol response.
    Trevisan M, Matkovic U, Cusinato R, Toppo S, Palù G, Barzon L.
    J Cell Physiol; 2009 Dec 15; 221(3):629-41. PubMed ID: 19688782
    [Abstract] [Full Text] [Related]

  • 18. Metformin decreases angiogenesis via NF-kappaB and Erk1/2/Erk5 pathways by increasing the antiangiogenic thrombospondin-1.
    Tan BK, Adya R, Chen J, Farhatullah S, Heutling D, Mitchell D, Lehnert H, Randeva HS.
    Cardiovasc Res; 2009 Aug 01; 83(3):566-74. PubMed ID: 19414528
    [Abstract] [Full Text] [Related]

  • 19. The antisense oligonucleotide ISIS 2922 prevents cytomegalovirus-induced upregulation of IL-8 and ICAM-1 in cultured human fibroblasts.
    Cinatl J, Kotchetkov R, Weimer E, Blaheta RA, Scholz M, Vogel JU, Gümbel HO, Doerr HW.
    J Med Virol; 2000 Mar 01; 60(3):313-23. PubMed ID: 10630964
    [Abstract] [Full Text] [Related]

  • 20. Angiogenic response caused by oncolytic herpes simplex virus-induced reduced thrombospondin expression can be prevented by specific viral mutations or by administering a thrombospondin-derived peptide.
    Aghi M, Rabkin SD, Martuza RL.
    Cancer Res; 2007 Jan 15; 67(2):440-4. PubMed ID: 17234749
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.